Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A1 | P22736 | 1/20 | 0.59 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.59 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.59 |
| ▸ | CDC25B | P30305 | 1/20 | 0.52 |
| ▸ | MMP3 | P08254 | 1/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.47 |
| ▸ | PLK1 | P53350 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5012386 | 0.95 | NR4A1 (0.59) | NR4A1NR4A2NR4A3CDC25BMMP3 | |
| SCHEMBL10607519 | 0.89 | NR4A1 (0.48) | NR4A1NR4A2NR4A3CDC25BMMP3 | |
| SCHEMBL2494543 | 0.85 | NR4A1 (0.62) | NR4A1NR4A2NR4A3CDC25BMMP3 | |
| SCHEMBL383491 | 0.84 | RAB9A (0.51) | NR4A1NR4A2NR4A3CDC25BALDH1A1 | |
| SCHEMBL23709160 | 0.80 | NR4A1 (0.57) | NR4A1NR4A2NR4A3CDC25BMMP3 | |
| SCHEMBL4057395 | 0.80 | NR4A1 (0.57) | NR4A1NR4A2NR4A3CDC25BMMP3 | |
| SCHEMBL6750240 | 0.79 | RAB9A (0.54) | CDC25BALDH1A1HPGDSMN1; SMN2L3MBTL1 | |
| SCHEMBL1933651 | 0.78 | NR4A1 (0.55) | NR4A1NR4A2NR4A3CDC25BMMP3 | |
| SCHEMBL547632 | 0.78 | CDC25B (0.69) | NR4A1NR4A2NR4A3CDC25BMMP3 | |
| SCHEMBL31371895 | 0.78 | NR4A1 (0.55) | NR4A1NR4A2NR4A3CDC25BMMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4928 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2991655-B1 | COMPOSITIONS AND METHODS FOR ALTERING SECOND MESSENGER SIGNALING | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2024-04-10 | — | — | EP | claimed |
| EP-3606528-B1 | TRICYCLIC COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 (GSK3) INHIBITORS AND USES THEREOF | BROAD INST INC (US) | 2023-10-18 | — | — | EP | claimed |
| EP-3649135-B1 | SYNTHESIS OF HALICHONDRINS | HARVARD COLLEGE (US) | 2022-12-28 | — | — | EP | claimed |
| US-20220380845-A1 | Asymmetric Rhodamine Dye and Use Thereof in Biological Assays | Life Technologies Corporation | 2022-12-01 | — | — | US | claimed |
| US-20220056041-A1 | Modified Rhodamine Dye and use Thereof in Biological Assays | Life Technologies Corporation | 2022-02-24 | — | — | US | claimed |
| US-11241435-B2 | Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis | THE GENERAL HOSPITAL CORPORATION (US) | 2022-02-08 | — | — | US | claimed |
| CN-113614182-A | Modified rhodamine dyes and their use in bioassays | 生命技术公司 | 2021-11-05 | — | — | CN | claimed |
| EP-3898842-A1 | MODIFIED RHODAMINE DYE AND USE THEREOF IN BIOLOGICAL ASSAYS | Life Technologies Corporation (US) | 2021-10-27 | — | — | EP | claimed |
| EP-3898841-A1 | ASYMMETRIC RHODAMINE DYE AND USE THEREOF IN BIOLOGICAL ASSAYS | Life Technologies Corporation (US) | 2021-10-27 | — | — | EP | claimed |
| EP-3172213-B1 | MACROCYCLIC KINASE INHIBITORS AND USES THEREOF | DANA FARBER CANCER INST INC (US) | 2021-09-22 | — | — | EP | claimed |
| US-5872244-A | STEPWISE CREATION OF PHOSPHODIESTER BONDS BETWEEN DESIRED NUCLEOSIDES RESULTING IN THE SYNTHESIS OF POLYNUCLEOTIDES HAVING A PREDETERMINED NUCLEOTIDE SEQUENCE | Hiatt, Andrew C. (US) | 1999-02-16 | — | — | US | claimed |
| EP-0777675-B1 | SOLID SUPPORT REAGENTS FOR THE SYNTHESIS OF 3'-NITROGEN CONTAINING POLYNUCLEOTIDES | PERKIN ELMER CORP (US) | 1999-01-27 | — | — | EP | claimed |
| EP-0781293-A1 | COMPOSITIONS FOR ENZYME CATALYZED TEMPLATE-INDEPENDENT CREATION OF PHOSPHODIESTER BONDS USING PROTECTED NUCLEOTIDES | Hiatt, Andrew C. (US) | 1997-07-02 | — | — | EP | claimed |
| EP-0777675-A1 | SOLID SUPPORT REAGENTS FOR THE SYNTHESIS OF 3'-NITROGEN CONTAINING POLYNUCLEOTIDES | THE PERKIN-ELMER CORPORATION (US) | 1997-06-11 | — | — | EP | claimed |
| US-5552471-A | Solid support reagents for the synthesis of 3'-Nitrogen containing polynucleotides | THE PERKIN-ELMER CORPORATION (US) | 1996-09-03 | — | — | US | claimed |
| WO-1996007669-A1 | COMPOSITIONS FOR ENZYME CATALYZED TEMPLATE-INDEPENDENT CREATION OF PHOSPHODIESTER BONDS USING PROTECTED NUCLEOTIDES | ROSE-HIATT BIOTECHNOLOGY PARTNERSHIP (US) | 1996-03-14 | — | — | WO | claimed |
| WO-1996005215-A1 | SOLID SUPPORT REAGENTS FOR THE SYNTHESIS OF 3'-NITROGEN CONTAINING POLYNUCLEOTIDES | THE PERKIN ELMER CORPORATION (US) | 1996-02-22 | — | — | WO | claimed |
| US-5478928-A | Useful as antiviral agents in the treatment and prevention of AIDS | SOUTHERN RESEARCH INSTITUTE (US) | 1995-12-26 | — | — | US | claimed |
| WO-1995011685-A1 | 2',3'-DIDEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AGENTS | SOUTHERN RESEARCH INSTITUTE (US) | 1995-05-04 | — | — | WO | claimed |
| US-5189027-A | Hypotensive agent, vasoconstriction | YAMASA SHOYU KABUSHIKI KAISHA (JP) | 1993-02-23 | — | — | US | claimed |